PBH — Prestige Consumer Healthcare Inc.
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1295947 ·
Last close
$48.22
Market Cap
$2.29B
52W High
$71.07
52W Low
$41.77
ADV30
595,145
Next earnings
2027-02-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 336,307,000 | 172,538,000 | 80,712,000 | 25,295,000 | 4,721,661,000 | 46,515,000 | 2,776,996,000 |
| Jun 2026 | 265,710,000 | 136,188,000 | 52,520,000 | 29,177,000 | 4,568,573,000 | 89,127,000 | 2,651,857,000 |
| Mar 2026 | 281,617,000 | 146,299,000 | 75,492,000 | 53,928,000 | 3,494,313,000 | 63,868,000 | 1,606,797,000 |
| Dec 2025 | 283,444,000 | 157,369,000 | 82,491,000 | 46,696,000 | 3,494,743,000 | 62,373,000 | 1,665,292,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$229,781,000
Investing CF
$-1,334,615,000
Financing CF
$1,031,920,000
CapEx
$-15,565,000
Dividends Paid
—
Buybacks
$-46,508,000
EPS Diluted TTM
$3.24
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$1,800,575,000
Inventory
$179,203,000
Receivables
$244,124,000
ST Investments
—
EBIT TTM
$278,648,000
Pretax Income TTM
$212,577,000
Interest Exp TTM
$66,071,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,167,078,016
EBITDA
$345,083,008
Free Cash Flow
$147,570,368
Enterprise Value
$4,117,855,488
Total Cash
$46,515,000
Total Debt
$2,127,243,008
Shares Out
47,397,106
Trailing EPS
$3.24
Book Value
$41.03
ROE
8.2%
ROA
4.7%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 1,088,705,000 | 309,409,000 | 190,301,000 | 3,494,313,000 | 1,606,797,000 | 1,887,516,000 | 257,627,000 |
| Mar 2025 | 1,137,762,000 | 349,241,000 | 214,605,000 | 3,402,218,000 | 1,567,321,000 | 1,834,897,000 | 251,515,000 |
| Mar 2024 | 1,125,357,000 | 342,429,000 | 209,339,000 | 3,318,417,000 | 1,663,333,000 | 1,655,084,000 | 248,926,000 |
| Mar 2023 | 1,127,725,000 | 347,802,000 | -82,306,000 | 3,353,729,000 | 1,906,645,000 | 1,447,084,000 | 229,716,000 |
TTM Snapshot
Revenues TTM
$1,104,885,000
NetIncome TTM
$172,012,000
OpCashFlow TTM
—
Assets (Latest)
$4,568,573,000
Forward EPS
$5.10
Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)
max pain strike: $45.00 · spot: $50.62 · call volume: 2 · put volume: 40Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| GLPGF | Lakefront Biotherapeutics NV | $2.30B | $35.15 | — |
| PHVS | Pharvaris N.V. | $2.27B | $32.28 | — |
| LKFT | Lakefront Biotherapeutics NV | $2.25B | $34.39 | — |
| NAMS | NewAmsterdam Pharma Co N.V. | $2.33B | $19.39 | — |
| GRFS | Grifols SA | $2.23B | $8.63 | — |
News headlines (Yahoo Finance, 1h cache)
Prestige Consumer Healthcare (PBH) Stock May Be Undervalued Despite Lowered Revenue Guidance
2026-11-16 23:24 · Yahoo
Prestige Consumer Healthcare Q2 Earnings Call Highlights
2026-11-08 03:14 · Yahoo
Prestige Consumer Healthcare (PBH) Stock Dropped, So What Is Driving Attention Now?
2026-11-06 15:15 · Yahoo
Prestige Consumer Healthcare Inc (PBH) (Q2 2027) Earnings Call Highlights: Revenue Surges 23% ...
2026-11-06 09:11 · Yahoo
Prestige Consumer Healthcare Stock In Focus After Revenue Rose But Profit Fell
2026-11-05 14:18 · Yahoo
Compared to Estimates, Prestige Consumer Healthcare (PBH) Q2 Earnings: A Look at Key Metrics
2026-11-05 13:30 · Yahoo
Prestige Consumer Healthcare (PBH) Beats Q2 Earnings and Revenue Estimates
2026-11-05 11:35 · Yahoo
Prestige Consumer Healthcare: Fiscal Q2 Earnings Snapshot
2026-11-05 11:16 · Yahoo
Prestige Consumer Healthcare Inc. Reports Fiscal 2027 Second Quarter Results
2026-11-05 11:00 · Yahoo
Is it Apt to Retain Prestige Consumer Stock in Your Portfolio Now?
2026-10-15 13:23 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.